This week, Precision Diabetes, Inc. presented data demonstrating that the 1,5-anhydroglucitol blood test (GlycoMark®) is more accurate than commonly used diabetes tests in predicting mortality in hospitalized COVID-19 patients with and without diabetes. The study, “1,5-anhydroglucitol is an Independent Predictor of Mortality in Patients with COVID-19,” was presented at the American Heart Association (AHA) 2021 Scientific...
People Over 40 with Type 1 Diabetes and COVID-19 Are More Likely to be Hospitalized
Adults with type 1 diabetes need to be extra cautious of COVID-19 as they are more likely to be hospitalized and die, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. People with diabetes are at higher risk for COVID-19-related complications, especially if they are over the age of...
Kids in Lockdown: How COVID-19 Affected Children with Type 1 Diabetes
ENDO 2021 presented a plethora of research detailing how COVID-19 impacted a number of endocrine comorbidities. However, two studies in particular took a closer look at how the virus impacted pediatric patients with type 1 diabetes. Each year, ENDO is something of an “embarrassment of riches” because it consists of four days packed with the...
Over the Edge: Is COVID-19 Introducing a New Type of Diabetes?
Researchers are exploring the complex, push-pull relationship between COVID-19 and diabetes. Is the virus truly the cause of a new type of diabetes or is it merely hastening an inevitable development in susceptible patients? From the earliest days of the COVID-19 pandemic, its effects on glycemic control have been among its challenges. Patients with...
Proof-of-Concept Study Shows CGM Benefit in Patients with COVID-19
A proof-of-concept study recently published in Diabetes Care shows how inpatient diabetes technology is advancing and can provide meaningful improvements in care today and in a post-pandemic world. The research team, led by Francisco J. Pasquel, MD, MPH, assistant professor of medicine in the Division of Endocrinology at Emory University in Atlanta, write that point-of-care...
Supplements May Protect Those with Low Vitamin D Levels from Severe COVID-19
Study finds more than half of patients with low vitamin D do not receive supplements. Patients with low vitamin D levels who are hospitalized for COVID-19 may have a lower risk of dying or requiring mechanical ventilation if they receive vitamin D supplementation of at least 1,000 units weekly, according to a study presented virtually...
As COVID-19 vaccines continue to be distributed, the world’s leading bone health research, clinical, and patient advocacy organizations ASBMR, Endocrine Society, AACE, ECTS, NOF, and IOF provide recommendations to assist clinicians in managing osteoporosis treatments for their patients who plan to get vaccinated. The full guidance document with supporting evidence is available online. Experts agree...
No Place Like Home: How Environmental Factors Impact Disparities in Obesity Treatment
ENDO 2021 will feature “How Do We Confront Disparities in Obesity and COVID-19 Treatment?” which will have three different programs with individual Q&A sessions on Monday March 22 at 12:15 p.m. Rebecca E. Hasson, PhD, FACSM, highlights what attendees can expect from her presentation on obesity-related metabolic risk factors caused by one’s environment. ENDO 2021...
